TITLE

The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol

AUTHOR(S)
Kakia, Aloysious; Wiysonge, Charles S.; Ochodo, Eleanor A.; Awotedu, Abolade A.; Ristic, Arsen D.; Mayosi, Bongani M.
PUB. DATE
January 2016
SOURCE
BMJ Open;2016, Vol. 6 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
112400129

 

Related Articles

  • Clinical review: Intrapericardial fibrinolysis in management of purulent pericarditis. Augustin, Pascal; Desmard, Mathieu; Mordant, Pierre; Lasocki, Sigismond; Maury, Jean-Michel; Heming, Nicholas; Montravers, Philippe // Critical Care;2011, Vol. 15 Issue 2, p10022 

    Purulent pericarditis (PP) is a potentially life-threatening disease. Reported mortality rates are between 20 and 30%. Constrictive pericarditis occurs over the course of PP in at least 3.5% of cases. The frequency of persistent PP (chronic or recurrent purulent pericardial effusion occurring...

  • Malignant Pericardial Effusion Treated with Intrapericardial Bleomycin. Thai, Vincent; Oneschuk, Doreen // Journal of Palliative Medicine;Apr2007, Vol. 10 Issue 2, p281 

    A letter to the editor is presented about malignant pericardial effusion treated with intrapericardial bleomycin.

  • Systematic review of percutaneous interventions for malignant pericardial effusion. Virk, Sohaib A.; Chandrakumar, David; Villanueva, Claudia; Wolfenden, Hugh; Liou, Kevin; Cao, Christopher // Heart;Oct2015, Vol. 101 Issue 20, p1619 

    The present systematic review assessed the safety and efficacy of percutaneous interventions for malignant pericardial effusion (MPE), with primary endpoint of recurrence of pericardial effusion. Electronic searches of six databases identified thirty-one studies, reporting outcomes following...

  • Percutaneous treatment in patients presenting with malignant cardiac tamponade. Marcy, P.; Bondiau, P.; Brunner, P.; Marcy, P Y; Bondiau, P Y // European Radiology;Sep2005, Vol. 15 Issue 9, p2000 

    The percutaneous treatment of pericardial effusion resulting in cardiac tamponade has undergone an evolution in recent years with the use of less invasive drainage techniques in selected cases. To determine optimal therapy modalities for oncology patients with malignant pericardial tamponade...

  • Massive intrapericardial herniation of stomach following pericardial window. Murari, V. J.; Alexander, G. L.; Cassivi, S. D. // Hernia;Aug2004, Vol. 8 Issue 3, p273 

    Herniation of intra-abdominal contents into the pericardial cavity is rare. We describe one such case occurring after creation of a pericardioperitoneal window for drainage of a pericardial effusion. The diagnosis of an intrapericardial hernia should be considered in patients presenting with...

  • Tamponade secundario a derrame pericárdico masivo, forma de presentación de hipotiroidismo primario. Gutiérrez Villena, Alejandro Napoleón; Quezada Burgos, César; Morales Cervantes, Lucero Ivette // Medicina Interna de Mexico;jul/ago2012, Vol. 28 Issue 4, p389 

    The cardiac tamponade is a complication of pericardial effusion where the collapse of the right cavities secondary to increased intrapericardial pressure decreased cardiac conditions and shock has multiple causes and almost all the causes of pericardial effusion may condition this entity,...

  • Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review. Dawei Chen; Yan Zhang; Fang Shi; Minghuan Li; Hui Zhu; Li Kong; Jinming Yu // OncoTargets & Therapy;2015, Vol. 8, p2767 

    Malignant pericardial effusion (MPCE) is a common complication of advanced malignant tumors, and interferes severely with patient prognosis and quality of life. The standard treatment for this complication is intracavitary perfusion of chemotherapeutic drugs, which is limited by unsatisfactory...

  • A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Kunitoh, H; Tamura, T; Shibata, T; Imai, M; Nishiwaki, Y; Nishio, M; Yokoyama, A; Watanabe, K; Noda, K; Saijo, N; JCOG Lung Cancer Study Group, Tokyo, Japan // British Journal of Cancer;2/10/2009, Vol. 100 Issue 3, p464 

    Safety and efficacy of intrapericardial (i.p.c.) instillation of bleomycin (BLM) following pericardial drainage in patients with malignant pericardial effusion (MPE) remain unclear. Patients with pathologically documented lung cancer, who had undergone pericardial drainage for MPE within 72 h of...

  • Intrapericardial fibrinolysis in purulent pericarditis-case report. Dybowska, Małgorzata; Kazanecka, Barbara; Kuca, Paweł; Burakowski, Janusz; Czajka, Cezary; Grzegorczyk, Franciszek; Gralec, Renata; Tomkowski, Witold // International Journal of Emergency Medicine;10/8/2015, Vol. 8 Issue 1, p1 

    Purulent pericarditis (PP) continues to result in a very serious prognosis and high mortality. The most serious complication of pericarditis is constriction. Intrapericardial administration of fibrinolytic agents, although controversial, can prevent the development of constrictions. We present...

  • Management of neoplastic pericardial effusion. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;05/25/97, Vol. 10 Issue 5, p23 

    Describes a management approach for neoplastic pericardial effusion. Treatment of symptomatic tamponade; Subxiphoid pericardiostomy; Intrapericardial instillation of chemotherapeutic agents.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics